OneMedNet Corporation (NASDAQ:ONMD – Get Free Report) insider Jeffrey Yu purchased 172,414 shares of the business’s stock in a transaction dated Tuesday, June 16th. The shares were purchased at an average cost of $0.58 per share, for a total transaction of $100,000.12. Following the completion of the purchase, the insider directly owned 8,621,680 shares of the company’s stock, valued at approximately $5,000,574.40. This represents a 2.04% increase in their position. The purchase was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.
Jeffrey Yu also recently made the following trade(s):
- On Wednesday, April 1st, Jeffrey Yu acquired 903,614 shares of OneMedNet stock. The stock was bought at an average price of $0.83 per share, with a total value of $749,999.62.
OneMedNet Trading Down 10.2%
Shares of ONMD stock opened at $0.50 on Wednesday. OneMedNet Corporation has a 1-year low of $0.33 and a 1-year high of $4.22. The stock has a market cap of $27.27 million, a price-to-earnings ratio of -10.02 and a beta of 1.12. The stock has a 50-day moving average of $0.86 and a 200-day moving average of $0.95.
Institutional Inflows and Outflows
Large investors have recently modified their holdings of the stock. Exencial Wealth Advisors LLC increased its stake in OneMedNet by 1.3% in the 4th quarter. Exencial Wealth Advisors LLC now owns 3,644,861 shares of the company’s stock valued at $4,009,000 after buying an additional 45,401 shares during the last quarter. State Street Corp grew its position in shares of OneMedNet by 41.5% in the fourth quarter. State Street Corp now owns 116,700 shares of the company’s stock valued at $128,000 after purchasing an additional 34,200 shares in the last quarter. Jane Street Group LLC bought a new stake in shares of OneMedNet during the 4th quarter valued at $119,000. Virtu Financial LLC purchased a new stake in OneMedNet during the 4th quarter worth about $48,000. Finally, HRT Financial LP bought a new position in OneMedNet in the 4th quarter worth about $32,000. Institutional investors own 0.95% of the company’s stock.
Analyst Ratings Changes
ONMD has been the topic of a number of research analyst reports. Wall Street Zen cut shares of OneMedNet from a “hold” rating to a “sell” rating in a research report on Saturday, May 23rd. Weiss Ratings reissued a “sell (e+)” rating on shares of OneMedNet in a research note on Monday, June 1st. One equities research analyst has rated the stock with a Sell rating, According to data from MarketBeat.com, the stock currently has an average rating of “Sell”.
View Our Latest Report on ONMD
About OneMedNet
OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.
Featured Stories
- Five stocks we like better than OneMedNet
- Flying Under the Radar: Lockheed Martin’s $2.8B Stealth Setup
- Bread’s Comeback Is Real—But Is the Easy Money Gone?
- Ollie’s Stock Has Lagged Despite Earnings Beats—What’s Holding It Back?
- Fox Captures The Living Room With $22B Roku Buy
Receive News & Ratings for OneMedNet Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OneMedNet and related companies with MarketBeat.com's FREE daily email newsletter.
